terzepatide vs semaglutide In adults with obesity but not diabetes, tirzepatide leads to significantly greater weight loss than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Frontiers | Tirzepatide against obesity

The platform describes access to FDA-approved branded GLP-1 medications alongside compounded options and non-GLP-1 medications - a wide range of medication options within a single telehealth program

[1] [2] According to the FDA prescribing information for these medications, changes in urine odor are not listed as a direct adverse effect of semaglutide, though some patients have anecdotally reported noticing differences in their urine smell during treatment

A lot of research would need to be done to know whether that would work and who might benefit

Future randomised controlled trials should specifically evaluate the effectiveness of novel AOMs for long-term weight management in older adults with obesity, carefully considering the impact on body composition and functional ability, as well as health economics

Fans of the peptide claim that it helps with weight loss, muscle gain, energy, and joint health, among other aging-related woes